The application of rTMS in Parkinson's disease

Parkinson's disease is the second most common neurodegenerative disorder worldwide. Characterized by both motor and non-motor symptoms, patients of Parkinson’s disease classically display rest tremor, rigidity, bradykinesia, and a stooping posture. Also in the neurocognitive domain symptoms such as depression, anxiety, dementia, and autonomic dysfunctions are common for patients who suffer from Parkinson’s disease (Beitz, 2014). In recent years, innovative therapies such as repetitive Transcranial Magnetic Stimulation (rTMS) have been applied to improve the quality of life of Parkinson’s disease patients. Additionally, diagnostic properties of TMS are being used to study Parkinson’s disease in patients. In the review article published by Lefaucheur et al., (2020) probable efficacy of high-frequency rTMS over the M1 and left DLPFC is found to treat motor symptoms and depressive feelings respectively in Parkinson's disease. In this webinar we cover the latest advancements regarding the application of (r)TMS in treatment and diagnosis of Parkinson’s disease. The symptoms of Parkinson’s disease will be discussed as well as rTMS treatment protocols. Furthermore, the latest scientific findings regarding TMS and Parkinson’s disease will be covered.

Prof. dr. Teus van Laar is a neurologist and clinical pharmacologist at the University Medical Centre Groningen (UMCG) ,  specialized in advanced treatments of Parkinson’s disease. During this webinar he will lecture about the application of rTMS for gait disorders and Parkinson’s. He will also cover the application of rTMS for treating visual hallucinations in Parkinson’s disease.

Emile D’Angremont is a PhD candidate at the research group of Prof. dr. Iris Sommer at the UMCG. His work covers Short-latency afferent inhibition (SAI) in Parkinson’s disease. He uses single-pulse TMS to study this physiological phenomenon that is seemingly dependent on the activation of acetylcholine.

We'll end the webinar with a online live demonstration of the Neural Navigator, a MRI-guided neuronavigation system for (r)TMS that can be used to accurately target neuroanatomical structures. 
  
The webinar will take place on the 25th of May, 2021 from 4PM  (CEST - Amsterdam time). Of course there will be ample room to ask questions. You can register here using our online form from the Zoom platform. A few days before the webinar, you will receive the Zoom link to the meeting by email. Participation is free for everyone.

Date: May 25th, 2021. 
Time: 04.00 PM (CEST - Amsterdam Time)
Program:

16.00h-16.25h CEST

Prof. dr. Teus van Laar
University of Groningen
rTMS treatment of gait disorders and visual hallucinations in Parkinson's disease
16.25h-16.50h CEST Emile D'Angremont
University of Groningen
Diagnostic TMS in Parkinson’s disease
16.50h-17.20h CEST Jord Vink
Brain Science Tools
Online live demonstration of the Neural Navigator

Emile D'Angremont

Emile D'Angremont

PhD-candidate, University of Groningen

Emile D'Angremont is a technical physician who tries to bridge the gap between modern technology and daily clinical practice. During his research as a PhD-candidate, he focusses on the prediction of how patients with Parkinson's disease with cognitive decline or visual hallucinations respond to treatment with cholinesterase inhibitors. For this goal he uses PET and TMS (short-latency afferent inhibition).
Teus van Laar

Teus van Laar

Professor, University of Groningen

Teus van Laar is a clinical neurologist by training, with special expertise in movement disorders, especially in Parkinson’s disease, and the effect of pharmacological interventions on this disease. He works at the University of Groningen, The Netherlands and has been the Medical Director of the Parkinson Expertice Center in Groningen since 2016.